Dr. Xi Chen is a Professor in the Department of Chemistry at the University of California, Davis, where he has been a faculty member since 2003. His research spans carbohydrate chemistry, glycobiology, and cancer biology, with notable contributions to chemoenzymatic methods for glycoconjugate synthesis. Dr. Chen's work focuses on developing hybrid chemical-enzymatic approaches to synthesize complex carbohydrates and glycoconjugates, characterizing glycosyltransferase mechanisms, and designing enzyme mutants for improved catalysis. He also investigates carbohydrate-based diagnostics and therapeutics, particularly in cancer and inflammatory diseases. His recent publications highlight interdisciplinary studies linking carbohydrate metabolism to p53 tumor suppression pathways and RNA-binding protein regulation in cancer. Awards include AAAS Fellow (2015), ACS Isbell Award (2012), and NSF CAREER Award (2006). He earned his Ph.D. at Wayne State University (2000) and B.S. at Xiamen University (1994). Scientific Awards American Association for the Advancement of Science Fellow (2015) Dean's Team Award for Excellence (2013) Carbohydrate Research Award for Creativity (2013) ACS CARB Horace S. Isbell Award (2012)
Herman Sintim is the Grace-Rupley Professor of Chemical Biology in the Department of Chemistry and Biochemistry at the University of Notre Dame, where he also serves as the Associate Director of the Harper Cancer Research Institute. He has previously held faculty positions at Purdue University and the University of Maryland at College Park, progressing from Assistant to Full Professor. His research is highly interdisciplinary, bridging organic chemistry, chemical biology, and drug discovery. Research Interests: Dr. Sintim's research focuses on understanding and modulating cyclic dinucleotide signaling pathways in both bacteria and mammalian immune systems. His lab explores the roles of molecules like c-di-GMP, c-di-AMP, and cGAMP in biofilm formation, virulence, and immune activation, particularly via the STING pathway. A major thrust is the development of small molecule probes and therapeutics targeting these pathways for use in cancer immunotherapy and as novel antibiotics. Additionally, his group pioneers the synthesis of new kinase inhibitors using multi-component reactions to combat drug resistance in cancer, targeting kinases such as FLT3, CDKs, and RET. The recent publications of the Sintim group reflect a strong trend in designing novel chemotypes for both STING modulation (agonists and antagonists) and kinase inhibition, with an emphasis on oral bioavailability and efficacy in animal models. These works span chemical synthesis, biochemical evaluation, and translational applications in oncology and immunology. Scientific Awards: Lafayette Lions Club Cancer Research Award (2022) Sigma Xi Distinguished Lecturer (2015) Camille Dreyfus Teacher-Scholar Award (2011) Allen Angerio Award for Excellence in Faculty Mentorship (2010) Kavli Fellow (2009) NSF CAREER Award (2008) Roche First Prize, Switzerland (2002) First Innocentive Awardee (2001) Pfizer UK PhD Prize (2001) ORS Fellowship, University of Oxford (2000) Pathfinder Scholarship, University College London (1996) Advising and Grants: While specific students are not listed, Dr. Sintim has a well-established record of mentoring, recognized by awards such as the Allen Angerio Award. He has secured major funding through grants like the NSF CAREER Award and has advanced drug discovery projects to the level of co-founding KinaRx LLC, indicating strong translational grant and entrepreneurial success. His leadership as Associate Director of a major cancer research institute further underscores his role in guiding research teams and collaborative science. Labs and Teams: The Sintim Research Group at Notre Dame operates at the intersection of synthetic organic chemistry and biological signaling, with active projects in cancer, inflammation, and antibiotic discovery. The lab employs integrated computational and experimental workflows and collaborates widely, as seen in multi-institutional publications involving researchers in pharmacology, oncology, and immunology.
Gregory C. Gray, MD, MPH, FIDSA is a Professor in Infectious Disease Epidemiology at the University of Texas Medical Branch (UTMB) in Galveston, Texas, with appointments across multiple departments including Internal Medicine (Infectious Diseases), Microbiology & Immunology, and Global Health & Emerging Diseases. Dr. Gray has conducted epidemiological studies of infectious diseases for over 25 years across five continents, with a particular focus on occupational disease transmission, especially respiratory viruses. His research has examined farmers, veterinarians, turkey workers, swine workers, poultry workers, horse workers, cattle workers, hunters, and military personnel. He pioneered the Millennium Cohort Study, a prospective cohort study of approximately 300,000 people projected to continue through 2068, and has led numerous large-scale vaccine trials. As a strong advocate for the One Health approach, Dr. Gray has established One Health centers in the USA, Romania, and China, and developed four graduate programs in One Health (PhD, MHS, and certificates). His recent research focuses on zoonotic spillover events, universal influenza vaccines, and coronavirus detection in agricultural settings, with numerous publications in 2024-2025 addressing H5N1 avian influenza, respiratory virus transmission, and environmental health impacts. Selected honors include: Department of Defense Legion of Merit Medal Secretary of Defense Medal for Outstanding Public Service Medal of Honor from Mongolia's Minister of Health The Peace Medal awarded by the President of Mongolia University of Texas Medical Branch Robert E. Shope, MD Professorship Dr. Gray has authored over 350 peer-reviewed manuscripts cited more than 21,000 times (H-index 76). His current research portfolio includes multiple active grants from the USDA, Fogarty International Center, and private industry focusing on zoonotic disease surveillance, influenza vaccines, and coronavirus detection in agricultural settings. He has mentored numerous students and established international collaborations across six continents.
Philippe Christe is an Associate Professor in the Department of Ecology and Evolution at the University of Lausanne (UNIL), Faculty of Biology and Medicine. His research centers on host-parasite interactions, with a focus on bats, birds, and their ectoparasites, integrating behavioral, physiological, and genetic approaches. He leads the Christe Group, which investigates evolutionary and ecological dynamics in host-parasite systems, particularly avian malaria and bat-mite relationships. He is actively involved in conservation initiatives, including the Jorat Peri-Urban Nature Park, and collaborates with KORA on human-wildlife interactions. Bachelor's degree in biology, UNIL (1989) PhD in Zoology and Animal Ecology, UNIL (1994) Philippe Christe’s research interests lie at the intersection of parasitology, evolutionary ecology, and conservation biology. He investigates how host defenses evolve in response to parasitic pressures, examining trade-offs between immunity and life history traits such as reproduction and survival. His work often integrates field studies with experimental and molecular techniques. Key model systems include Parus major (great tit) and Culex pipiens in avian malaria, and bat species with their ectoparasitic mites. He also explores broader ecological interactions, including predator-prey dynamics and wildlife conservation in human-modified landscapes. His recent publications reflect a strong emphasis on disease ecology, wildlife conservation, and molecular methods. Articles span topics such as avian malaria transmission, lynx population dynamics, snow leopard behavior, and habitat fragmentation effects on insects. These works employ advanced techniques like DNA metabarcoding, spatial modeling, and long-term monitoring, demonstrating a trend toward interdisciplinary, data-driven ecological research with direct conservation applications. Dubois Foundation Prize for an educational CD-Rom on bats (2004) Communication Award from the Faculty of Biology and Medicine of UNIL (2017) Philippe Christe has supervised numerous PhD and Master’s students, contributing significantly to training the next generation of ecologists and evolutionary biologists. His group collaborates widely with institutions such as the Museum of Zoology in Lausanne and KORA, and participates in large-scale conservation projects involving snow leopards, lynx, and bats. He has been involved in research grants related to host-parasite coevolution, wildlife monitoring, and conservation strategies. His leadership in establishing the Jorat Peri-Urban Nature Park and involvement in the UNIL Interdisciplinary Center for Mountain Research highlight his commitment to applied science and environmental stewardship. He leads the Christe Group, which conducts research on host-parasite coevolution, with a focus on bats and their ectoparasites, and birds affected by avian malaria. The group combines fieldwork, laboratory experiments, and molecular analyses, and includes post-docs, PhD students, and technical staff. Collaborations extend to researchers in Bern, Paris, and Spain, fostering an international and interdisciplinary research environment.
Edward H. Hagen is a Professor of Evolutionary Anthropology at Washington State University, Vancouver. He holds a BA in Mathematics from UC Berkeley and a Ph.D. in Anthropology from UC Santa Barbara (1999). His postdoctoral work was at Humboldt University, Berlin, under Peter Hammerstein. Since 2007, he has been at WSU, leading the Bioanthropology Lab. His research integrates evolutionary approaches to medicine, focusing on substance use, mental health, child development, and leadership evolution. Key themes include evolutionary medicine, signaling theory in depression/suicidality, and the role of pharmacological plant use in human evolution. He has conducted fieldwork in the Central African Republic, Ecuador, and India. Hagen's work spans theoretical models (e.g., depression as bargaining signals) and empirical studies (e.g., tobacco use and helminth infection in hunter-gatherers). He has secured over $387,000 in grants, including NSF funding for projects on leadership, child signals of need, and smoking behavior. His lab explores topics like music's evolutionary roots (credible signaling hypothesis) and predator deterrence. He is active in academic discourse, critiquing popular theories like Dunbar's social bonding hypothesis for music evolution. His publications span evolutionary psychology, anthropology, and medical journals, emphasizing interdisciplinary approaches.
Vernita Gordon is an Associate Professor in the Department of Physics at the University of Texas at Austin (since 2018), previously serving as an Assistant Professor there from 2010 to 2018. She holds a Ph.D. in Physics from Harvard University (2003) and a B.Sc. in Physics and Mathematics from Vanderbilt University (1997). Her research focuses on understanding how physical characteristics like mechanics and spatial structure influence bacterial biofilms, particularly their interactions with the immune system and resistance to antibiotics. She has pioneered techniques such as laser trapping to manipulate biofilm structures and studies radiation effects on bacteria like Deinococcus radiodurans . Education: Ph.D. in Physics, Harvard University (2003) B.Sc. in Physics and Mathematics, Vanderbilt University (1997) Research Interests: Dr. Gordon’s work integrates biophysics, microbiology, and materials science to explore biofilm mechanics, bacterial mechanosensing, and radiation biology. Key areas include: How biofilm mechanics resist immune clearance and antibiotic treatment Role of surface stiffness and shear stress in biofilm initiation Radiation resistance mechanisms in Deinococcus radiodurans Development of tools like laser trapping to study biofilm structure Key Achievements: Recipient of the Elizabeth B. Gleeson Professorship (2023) and Texas Mindset Initiative Fellowship (2023) Provost’s Teaching Fellow (2020–2024) and multiple teaching awards Funded by NSF, NIH, and Cystic Fibrosis Foundation Published over 60 peer-reviewed articles, including in Nature , PNAS , and Biophysical Journal Advising & Outreach: She mentors graduate students in Physics, Microbiology, and Biomedical Engineering, emphasizing interdisciplinary training. Her group actively recruits undergraduates and collaborates with industry partners like Solvay and the College of Pharmacy. Outreach includes lesson plans for high school STEM education and community science initiatives. Labs & Collaborations: Her lab uses advanced microscopy, microrheology, and computational modeling. Key collaborations include work with the Contreras Lab (UT Austin Chemical Engineering) on radiation-resistant bacteria and the Raizen Lab (UT Austin Physics) on self-sterilizing surfaces.
Dr. Alexandre Marques is an Assistant Professor at the University of Southern Mississippi. His expertise spans Microbiology, Immunology, and Parasitology, with a focus on vaccine development against parasitic infections like Leishmaniasis, Chagas disease, and Malaria. He holds a PhD from the Universidade de São Paulo (2007) and teaches courses such as Gen Microbiology and Microorg Hth Di at the university. His research integrates immunological, clinical, and molecular approaches to understand parasitic disease mechanisms and therapeutic interventions. Notable areas include α-Gal immunization strategies, transcriptomic analysis of breast cancer, and vaccine design against Leishmania. He has also explored applications in aquaculture nutrition and cosmetic safety assessments. Dr. Marques’ work spans interdisciplinary collaborations, including veterinary medicine, nanotechnology-based drug delivery, and antimicrobial stewardship in pediatrics. His contributions to animal models for Chagas disease and canine visceral leishmaniasis highlight translational research impact. Key themes in his publications include immune response modulation, pathogen-host interactions, and biomarker discovery in chronic infections. He has published over 50 articles across microbiology, immunology, and biomedical engineering since 2007.
Lieuwke Kranenburg is an Assistant Professor at the Faculty of Veterinary Medicine , Utrecht University , specializing in Equine Internal Medicine . She provides patient care at the University Equine Clinic and teaches Master's courses in equine digestion , infectious diseases , and skin problems . Research Focus: Equine internal medicine, digestive diseases, infectious pathogens, metabolic disorders Professional Certifications: EBVS® European Veterinary Specialist in Equine Internal Medicine International Collaboration: Trained Chinese veterinarians at Heilan Equestrian Centre Publications highlight her work on equine gastric disease management, diagnostic imaging, infectious disease epidemiology, and metabolic research. She contributes to equine clinical research through peer-reviewed journals and conference abstracts. Professional Involvement: Former board member of the Equine Medicine Group and current GGP representative for FEEVA, maintaining professional networks and advancing equine veterinary practice.
Balázs Rada is an Associate Professor in the Department of Infectious Diseases at the University of Georgia's College of Veterinary Medicine. His research focuses on mechanisms of respiratory innate immunity, particularly in cystic fibrosis lung disease and host-pathogen interactions involving pathogens like Pseudomonas aeruginosa, Staphylococcus aureus, and influenza virus. Key projects include investigating neutrophil biology, reactive oxygen species in airway defenses, and therapeutic modulation of innate immunity. His lab, the Rada Laboratory, is based in Athens, Georgia, and emphasizes translational research in respiratory disease pathogenesis. Research interests span cystic fibrosis airway inflammation, antimicrobial therapies, and the role of neutrophil extracellular traps (NETs) in lung diseases. Collaborative efforts aim to develop novel treatments targeting innate immune dysfunction.
Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.
Kuo-Fen Lee, PhD is a Professor at the Salk Institute for Biological Studies, holding the prestigious Helen McLoraine Chair of Molecular Neurobiology. He leads the Clayton Foundation Laboratories for Peptide Biology, where his research focuses on nerve regeneration, spinal cord injury, and molecular mechanisms underlying neural development and neurodegenerative diseases. His work bridges basic neuroscience with potential therapeutic applications for conditions like ALS, paralysis, and Alzheimer's disease. Dr. Lee received his educational training from multiple prestigious institutions: a degree in Plant Pathology from National Taiwan University; an MS in Cancer Enzymology and Cell Differentiation from National Yang-Ming Medical College, Taiwan; a PhD in Endocrinology from Baylor College of Medicine, Houston; and completed his postdoctoral training at the Whitehead Institute for Biomedical Research. His primary research interests center on understanding why humans cannot regenerate damaged nerves while many other animals can. Dr. Lee has made significant discoveries regarding the p45 protein, which promotes nerve regrowth in mice but is absent in humans (who instead have p75, which inhibits nerve growth). His laboratory also studies neuregulin signaling, neuromuscular synapse formation, and the role of various proteins like nestin in neural development and maintenance. His work often employs mouse models to investigate spinal cord injury, pain pathways, and neurodegenerative conditions. Analysis of Dr. Lee's recent publications reveals a consistent focus on molecular neurobiology with particular emphasis on neural signaling pathways, synaptic maintenance, and nerve regeneration mechanisms. His research spans from basic molecular mechanisms to potential therapeutic applications, with increasing attention to pain pathways, Alzheimer's disease models, and the intersection of neuroscience with immunology and metabolism in recent years. As holder of the Helen McLoraine Chair of Molecular Neurobiology, Dr. Lee has received significant institutional recognition for his contributions to neuroscience. While specific awards aren't detailed in the provided text, his sustained funding and leadership position indicate substantial peer recognition in his field. Dr. Lee's research program involves extensive collaboration with other neuroscience laboratories, as evidenced by his numerous co-authored publications across various neuroscience subdisciplines. His work has been consistently funded, allowing for the maintenance of an active research laboratory focused on nerve regeneration and molecular neurobiology. The Clayton Foundation Laboratories for Peptide Biology serves as the primary research environment for Dr. Lee's team, where they investigate molecular mechanisms of nerve development, regeneration, and degeneration using advanced genetic, molecular, and cellular approaches. The laboratory maintains active research programs in multiple areas of neural signaling and development.
Matti Sällberg is a Professor in Biomedical Analysis at Karolinska Institutet's Department of Laboratory Medicine, leading the VIVAC research group focused on vaccines and immunotherapies against viruses and cancer. He earned his DDS and PhD from Karolinska Institutet (1988-1992), followed by postdoctoral research at The Scripps Research Institute (1994-1996). As a leader in infectious disease and hepatology, his research addresses chronic viral hepatitis, cancer prevention, and gene/cell-based therapies (GTMPs/ATMPs). He has directed the Department of Laboratory Medicine (2011-2022) and actively teaches in biomedical laboratory science, dentistry, medicine, and nursing programs. Key research areas include SARS-CoV-2 vaccine development (OPENCORONA consortium), hepatitis B/D/C therapies, and Crimean-Congo hemorrhagic fever vaccines. His work combines basic science with translational efforts at Karolinska's ANA Futura facility. Notable projects include a phase I clinical trial for a broad-acting SARS-CoV vaccine and preclinical testing of hepatitis therapies. Collaborations span academia and industry, with funding from the Swedish Cancer Society, EU, and VINNOVA. He oversees advanced techniques like viral propagation, flow cytometry, and adoptive cell therapy manufacturing. Grants include a 2024 Swedish Cancer Society award for hepatitis-related cancer therapies and a 2022 Swedish Research Council grant for the Doctoral Program in Advanced Therapies. His team maintains an active lab with researchers like Lars Frelin and Gustaf Ahlén. Future work emphasizes expanding vaccine platforms against emerging pathogens and optimizing immuno-therapies for solid tumors.
Dr. Ali Nazmi is an Assistant Professor in the Department of Animal Sciences and the Food for Health Discovery Theme at The Ohio State University. He holds affiliations within the College of Food, Agricultural, and Environmental Sciences (CFAES). His research focuses on nutritional immunology, host-pathogen interactions in poultry and pigs, and the metabolic roles of intestinal immune cells. Nazmi obtained his B.Sc. in Poultry Production and M.Sc. in Poultry Breeding from Ain Shams University (Egypt), followed by a Ph.D. in Animal Biology from UC Davis (2017). He completed postdoctoral training in mucosal immunology at Vanderbilt University Medical Center before joining OSU in 2021. His recent work includes studies on intraepithelial lymphocytes in intestinal health, enteric disease resistance in poultry, and swine T cell biology. Key publications address mechanisms of necrotic enteritis in chickens, unconventional T cell subsets, and cytokine regulation in colitis models. Collaborations span avian immunology, swine immunology, and semen cryopreservation techniques. Education: B.Sc. (Ain Shams), M.Sc. (Ain Shams), Ph.D. (UC Davis) Postdoc: Vanderbilt University Medical Center (mucosal immunology) Key Research Themes: Nutritional Immunology, Mucosal Immunity, Avian/Porcine Health
Gerda de Vries is a Professor in the Department of Mathematics & Statistical Sciences at the University of Alberta, Faculty of Science. Her research focuses on mathematical physiology, dynamical systems, and mathematical modeling, particularly in cellular biophysics, pattern formation, and systems biology. She has contributed extensively to understanding complex biological systems through interdisciplinary approaches combining mathematics and biology. Her work spans applications in radiation biology (e.g., cell cycle dynamics and low-dose radiation effects), biophysics (microtubule organization, motor proteins), ecology (predator-prey interactions, forest fire modeling), and education (adapting primary literature for STEM teaching). Recent research highlights include analyzing saddle-node bifurcations, bystander effects in radiation, and collective behavior in animal groups. De Vries has published over 50 peer-reviewed articles since 2000, with a focus on bridging abstract mathematical theory to concrete biological phenomena. Notable contributions include models of pancreatic β-cell dynamics, immune system versatility, and educational frameworks for mathematical biology. Her academic career includes leadership in curriculum development and interdisciplinary research, though no specific grants or awards are explicitly listed in the provided information.
Horst A. von Recum, PhD, is the Executive Vice Chair of the Case School of Engineering and a Professor in the Department of Biomedical Engineering at Case Western Reserve University. He is also a member of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His research focuses on developing novel platforms for molecular and cellular delivery, including affinity-based systems for controlled drug release and directed stem cell differentiation. Key applications include HIV therapies, wound healing, ocular disease treatments, and tissue engineering. His work emphasizes improving drug delivery precision through molecular interactions and enhancing stem cell viability for therapeutic use. Dr. von Recum’s research interests span drug delivery systems, biomaterials science, and regenerative medicine. His lab explores cyclodextrin polymers for sustained antibiotic release, affinity-driven drug refilling mechanisms, and engineering biocompatible materials to combat implant-related infections. Recently, his team has investigated microbiome interactions with neural implants and developed polymer-based solutions for localized chemotherapy. Notable contributions include advancements in PMMA bone cement composites for drug refillable depots, cyclodextrin hydrogels for controlled release, and affinity-based systems for anti-fibrotic treatments. His work bridges materials science with clinical applications, addressing challenges in orthopedic infections, neural interfaces, and cardiovascular regeneration. Scientific achievements include over 100 peer-reviewed publications. Research funding has supported projects on antimicrobial coatings, drug delivery mechanics, and stem cell differentiation. Dr. von Recum collaborates across disciplines to translate biomaterial innovations into clinical solutions.
